MétaCan
Menu
Back to cohort
Record W4405035337 · doi:10.1182/blood-2024-198905

“I Didn't Know I Had a Choice” - Patient Values and Preferences Regarding Resumption of Oral Anticoagulants after Gastrointestinal Bleeding

2024· article· en· W4405035337 on OpenAlexaffabout
Kevin Chien, Lindsay Cowley, Daniel Warner, Derek Little, Carol West, Roy Khalifé, Deborah Siegal

Bibliographic record

VenueBlood · 2024
Typearticle
Languageen
FieldMedicine
TopicAntiplatelet Therapy and Cardiovascular Diseases
Canadian institutionsUniversity of OttawaOttawa HospitalMcMaster University
Fundersnot available
KeywordsMedicineGastrointestinal bleedingDabigatranRivaroxabanApixabanWarfarinIntensive care medicineGastroenterologyInternal medicineAtrial fibrillation

Abstract

fetched live from OpenAlex

Introduction: Gastrointestinal (GI) bleeding is the most common complication of oral anticoagulant (OAC) treatment, which is often discontinued permanently after bleed cessation despite evidence of benefit to prevent future thromboembolic events. High-quality data to inform the management of OACs after GI bleeding are lacking, including when and how they should be resumed. Furthermore, patient/caregiver perspectives on this clinical situation and the factors influencing their decisions about OACs are poorly understood. Understanding patient/caregiver values and preferences is crucial for effective shared decision-making, particularly in situations of clinical uncertainty. This study aims to explore patient/caregiver perspectives to improve patient-centered care in the management of OACs after GI bleeding. Methods: We conducted a descriptive qualitative study using semi-structured interviews and focus groups. Adults who experienced GI bleeding within the previous two years while on OACs for any indication were recruited from outpatient clinics and inpatient wards at three tertiary care hospitals in Hamilton and Ottawa, Canada. Interviews were audio-recorded and transcribed verbatim. Two study investigators coded the first 15 transcripts inductively and the remainder of the transcripts were coded by one study investigator. Data analysis followed Braun and Clarke's reflexive thematic analysis. Results: Thirty-one participants were enrolled (29 individual interviews and 1 focus group). The most common indications for OACs were venous thromboembolism (55%) and atrial fibrillation (29%). Warfarin (35%), apixaban (29%), and rivaroxaban (26%) were the most prescribed OACs. Participants reported that physicians rarely solicited their preferences regarding whether and how OACs should be resumed following a GI bleed. Many were unaware that a decision needed to be made, assuming resumption was necessary to prevent thromboembolism. Despite this, participants did not perceive their lack of involvement in decision-making negatively. Participants experienced tension between the risks of bleeding and thromboembolic events after having a GI bleed while on OACs. Concerns about recurrent GI bleeding were often overshadowed by the fear of thromboembolism. Participants frequently perceived that not taking OACs would definitively result in a stroke or other thromboembolic events, with some equating discontinuation with death. In contrast, bleeding while on OACs was seen as a more transient and acceptable risk. Despite the prevailing fear of thromboembolic events, participants' trust in their physicians helped mitigate their fear of bleeding and thromboembolism. Participants felt their physicians had the expertise to balance these competing risks and had their best interest when determining the optimal management plan. As a result, they expressed strong reliance on their physicians' recommendations regarding OAC management. There was also a frequent desire for improved communication and education about their diagnoses and treatment options. Communication challenges were often experienced when multiple physicians were involved in their care, leading to confusion and uncertainty. However, participants felt that better understanding their diagnoses and the harms and benefits of OACs could help them navigate the tension between risk of bleeding and thromboembolism and make more informed decisions. Conclusions: Participants were often unaware of the need for decision-making regarding the resumption of OACs after a GI bleed. Although they experienced tension between the risks of bleeding and thromboembolism, the fear of thromboembolic events strongly influenced their desire to resume OACs. This underscores the need for physicians to address patient concerns and misconceptions about the risks and consequences of bleeding and thromboembolism. This study also highlights the importance of clear communication and patient education to mitigate the tension between bleeding and thromboembolism. These findings suggest that interventions targeting patient-physician communication and education about the harms and benefits of resuming OACs may help empower patients. Future research should focus on developing and testing such interventions to better support patients in making informed decisions about resuming OACs after a GI bleed.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.016
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Qualitative · Consensus signal: Qualitative
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.053

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.016
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0050.008
Scholarly communication0.0030.003
Open science0.0010.002
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.263
Teacher spread0.246 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designQualitative
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueBloodSame topicAntiplatelet Therapy and Cardiovascular DiseasesFrench-language works237,207